Frontlight ResearchEarly access
Trial site
Palo Verde Hematology Oncology
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Prostate cancer2 trials
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Myeloproliferative neoplasms1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Bristol-Myers Squibb1 trial
- Celgene1 trial
- Gilead Sciences1 trial
- Loxo Oncology, Inc.1 trial
- Nuvalent Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Colorectal cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026